Apoptosis in the liver;Apoptoza w wa̧trobie

Gastroenterologia Polska

Volumn 10, Issue 5, 2003, Pages 453-462

  Chmielewski, Marcin ^a   Linke, Krzysztof ^a   Zabel, Maciej ^b   Szuber, Lilianna ^a  

^a Klinika Gastroenterologii   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; Fas; Heptocyte; TNF

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; CYTOCHROME P450 2E1; EPIDERMAL GROWTH FACTOR; FAS ANTIGEN; FAS LIGAND; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; CYTOPATHOLOGY; HUMAN; INFLAMMATION; LIVER; LIVER CELL; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0344875606     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Nagata S.: Apoptosis by death factor. Cell, 1997, 88, 355-365.
2. Kawiak J., Hoser G., Skorski T.: Apoptosis and some of its medical implications. Folia Histochem. Cytobiol., 1998, 36, 99-110.
3. Galle P. R., Hofmann W.J., Walczak H., Schaler H., Otto G., Stremmel W., Krammer P.H., Runkel L.: Involvement of the CD95(APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med., 1995, 182, 1223-1230.
4. Au J., Panchal N., Li D., Gan Y.: Apoptosis: A New Pharmacodynamic Endpoint. Pharm. Res., 1997, 14, 1659-1668.
5. Jiang Z., Liu Y., Savas L., Smith L., Bonkovsky H., Baker S., Banner B.: Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases. Virchow Arch., 1997, 43, 189-199.
6. Kawahara A., Enari M., Talanian R.V., Wong W.W., Nagata S.: Fas-induced DNA fragemntation and proteolysis of nuclear proteins. Genes Cells, 1998, 3, 297-306.
7. Rivero M., Crespo J., Casafront F., Mayorga M., Fabrega E., Casafont F., Pons-Romero F.: Fulminant hepatitis by HBV. Role of Fas system. Hepatology, 1998, 28, 482A.
8. Dhillon A.P., Dusheiko G.M.: Pathology of hepatitis C virus infection. Histopathology, 1995, 26, 297-309.
9. Ando K., Hiroshi K., Kaneko T., Moriyama T., Muto Y., Kayagaki N., Yagita H., Okumura K., Imawari M.: Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus - specific human CTL. J. Immunol., 1997, 158, 5283-5291.
10. Luo K.X., Zhu Y.F., Zhang L.X., He H.T., Wang X.S., Zhang L.: In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J. Viral Hepat., 1997, 4, 303-307.
11. Hayaschi N., Mita E.: Fas system and apoptosis in viral hepatitis. J. Gastroenterol., Hepatol., 1997, 12, 223-226.
12. Bantley H., Lugering A., Poremba C., Lügering N., Held J., Domschke W., Schulze-Osthoff K.: Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology, 2001, 34, 758-767.
13. Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G., Ware C., Lai M.M.: Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1, and enhance TNF-induced apoptosis. J. Virol., 1998, 72, 3691-3697.
14. Lau J.Y., Xie X., Lai M.M., Wu P.C.: Apoptosis and viral hepatitis. Semin. Liver Dis., 1998, 18, 169-176.
15. Fujita T., Ishido S., Muramatsu S., Itoh M., Hotta H.: Suppresion of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem. Biophys. Res. Commun., 1996, 229, 825-831.
16. Hahn C.S., Cho Y.G., Kang B.S., Lester I.M., Hahn Y.S.: The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in human lymphoblasoid T cell line. Virology, 2000, 276, 127-137.
17. Calabrese F., Pontisso P., Pettenazzo E., Benvegnu L., Vario A., Chemello L., Alberti A.: Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels, Hepatology, 2000, 31, 1153-1159.
18. Guilhot S., Miller T., Cornman G., Isom H.C.: Apoptosis induced by tumor necrosis factor-alpha in rat hepatocyte cell lines expressing hepatitis B virus. Am. J. Pathol., 1996, 148, 801-814.
19. Kim H., Lee H., Yun Y.: X gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem., 1998, 273, 381-385.
20. Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G., Ware C., Lai M.M.: Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol., 1998, 72, 3691-3697,
21. Harda K., Ozaki S., Gershwin M.E., Nakanuma Y.: Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology, 1997, 26, 1399-1405.
22. Thatte U., Dahanukar S.: Apoptosis - Clinical Relevance and Pharmacological Manipulation. Drugs, 1997, 54, 511-532.
23. Patel T., Gores G.J.: Apoptosis and hepatobiliary disease. Hepatology, 1995, 21, 1725-1741.
24. Patel T., Bronk S.F., Gores G.J.: Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J. Clin. Invest., 1994, 94, 2183-2192.
25. Kurose I., Higuchi H., Miura S., Saito H., Watanabe N., Hokari R., Hirokawa M., Takaishi M., Zeki S., Nakamura T.: Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology, 1997, 25, 368-378.
26. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., Schulte-Hermann R.: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming groth factor beta 1. Proc. Natl. Acad. Sci. USA, 1992, 89, 5408-5412.
27. Juszczyk J.: Mechanizmy śmierci komórki wa̧trobowej. Zeszyty Hepatologiczne, 1999, 9, 19-23.
28. Batey R.G., Clancy R.L., Pang G.T., Cao Q.: Alcoholic hepatitis as a T-cell mediated disorder: an hypothesis. Alcohol. Clin. Exp. Res., 1999, 23, 1207-1209.
29. Kawahara H., Matsuda Y., Takase S.: Is apoptosis involved in alcoholic hepatitis? Alcohol, 1994, 29, 113-118.
30. Strand S., Hofmann W.J., Hug H., Müller M., Otto G., Strand D., Mariani S.M., Stremmel W., Krammer P.H., Galle P.R.: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumor cells-a mechanism of immune evasion? Nat. Med., 1996, 2, 1361-1366.
31. Ito Y., Takeda T., Umeshita K., Sakon M., Wakasa K., Matsuura N., Monden N.: Fas antigen expression in hepatocellular carcinoma tissues. Oncol. Rep., 1998, 5, 41-44.
32. Sue S.R., Chari R.S., Kong F.M., Mills J.J., Fine R.L., Jirtle R.L., Meyers W.C.: Transforming growth factor-beta receptors and mannose 6-phophate/insulin like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surg., 1995, 222, 171-178.
33. Hollstein M., Sidransky D., Vogelstein B., Harris C.C.: p53 mutations in human cancers. Science, 1991, 253, 49-53.
34. Harris C.C., Hollstein M.: Clinical implications of the p53 tumor suppressor gene. N. Engl. J. Med., 1993, 329, 1318-1327.
35. Buendia M.A.: Hepatitis B viruses and carcinogenesis. Biomed. Pharmacother., 1998, 52, 34-43.
36. Kerr J.F., Cooksley W.G., Searle J., Halliday J.W., Holder L., Roberts I., Burnett W., Powell L.W.: The nature of piecemeal necrosis in chronic active hepatitis. Lancet, 1979, 2, 827-828.
37. Schimamatsu K., Wanless I.R.: Role of ischemia in causing apoptosis, atrophy and nodular hyperplasia in human liver. Hepatology, 1997, 26, 343-350.
38. Gujral J.S., Bucci T.J., Farhood A., Jaeschke H.: Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology, 2001, 33, 397-405.
39. Rugtveit J., Haraldsen G., Hogasen A.K., Bakka A., Brandtzaeg P., Scott H.: Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. Gut, 1995, 37, 367-373.